PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Autophagy. Author manuscript; available in PMC 2010 August 26.
Published in final edited form as:
Autophagy. 2009 April; 5(3): 404–406.
Published online 2009 April 9.
PMCID: PMC2891286
NIHMSID: NIHMS111531

Toxoplasma - induced autophagy: a window into nutritional futile cycles in mammalian cells?

Abstract

The regulation and function of autophagy in response to metabolic signals is not yet well understood. A recent study from our laboratory indicates than an intracellular parasite, Toxoplasma gondii, derives nutritive benefit from the upregulation of host cell autophagy. We discuss these and related findings suggesting that autophagy in infected cells functions as part of a metabolic futile cycle. The hypothesis is presented that endogenous autophagy-based futile cycles may operate in normal mammalian cells, providing a substrate for manipulation by pathogens.

Keywords: Toxoplasma, parasites, autophagy, futile cycles, protein metabolism, mTOR, amino acids

Many studies have now shown a significant role for autophagy in cells infected by intracellular pathogens. In general, these studies have identified autophagy as a process that can contribute to the clearance of pathogen in the context of signals that activate host cell defense mechanisms.1 However, when such mechanisms are not active, host cell catabolic processes might conceivably play a pro-pathogen role by enhancing pathogen access to limiting nutrients.

A recent study from our laboratory provides evidence that the intracellular protozoan parasite, Toxoplasma gondii, is indeed able to exploit host cell autophagy for nutritive benefit.2 During its initial phase of rapid expansion, T. gondii invades many cell types and forms a specialized parasitophorous vacuole (PV), within which it replicates every 6–8 hours.3 This rapid growth is dependent on host cell nutrients, including amino acids, lipids and purines.46 The mechanism by which the parasite acquires host cell nutrients is not well understood, but recent evidence suggests that vesicular flow to the PV may be important. While the PV is fully isolated from fusion with host endosomes or lysosomes (provided anti-parasite functions have not been activated)7, infected cells display a remarkable concentration of host cell organelles around the PV, including endolysosomes, ER and mitochondria, the latter two tightly wrapping the PV. A recent study has shown that host lysosomes can enter the PV via PV invaginations associated with host microtubules.8 Therefore a host autophagic process that results in nutrient-rich lysosomes could conceivably serve as a pathway for nutrient flow to the parasite.

Our study supports this concept by demonstrating that parasite growth becomes dependent on host cell autophagy (assessed as dependence on host cell Atg5) only when the ambient amino acid concentration is reduced to physiological levels from the vast excess present in normal tissue culture medium. We also show that, under these conditions, host cell biomass is reduced by the parasite in an Atg5-dependent manner. Furthermore, parasite infection upregulates host autophagy and leads to a concentration near the PV of host Beclin 1 and vesicles bearing either phosphatidylinositol 3-phosphate or LC3.

The induction of autophagy under conditions of nutritional stress is thought to depend on negative regulation of the mTOR pathway, as a similar induction can be achieved in many cells with rapamycin, which inhibits the growth-promoting mTOR complex TORC1. We found, however, that T. gondii-induced autophagy does not involve mTOR inhibition, and even takes place in cells in which the mTOR pathway is hyperstimulated. Furthermore, in a separate, unpublished study, we found that if host cells are serum-deprived to reduce basal mTOR activity, Toxoplasma infection actually leads to upregulation of mTOR and protein synthesis in the host cell (Wang Y, Weiss LM, Orlofsky A, unpublished). The implication is that, in a physiological setting, T. gondii may simultaneously drive host protein metabolism in both anabolic and catabolic directions, generating (at least from the point of view of the host cell) a futile cycle.

The induction of a futile protein cycle might promote parasite growth by repositioning host amino acids into a parasite-accessible compartment (lysosomes). A second benefit might accrue to the parasite as a consequence of the considerable heat dissipation that accompanies protein synthesis,9 potentially resulting in increased ATP demand and elevated mitochondrial ATP production. The tight association of the PV with host mitochondria may facilitate parasite acquisition of the ATP produced. Thus, a futile ATP/energy cycle, secondary to the futile protein cycle, might amplify parasite capture of host resources (Fig. 1).

Figure 1
Hypothetical model for metabolic futile cycles driven by either parasite or endogenous signals. In the protein futile cycle (red arrows), amino acids (AA) are consumed by translation and returned from lysosomes (LY) via autophagy. AA-rich LY-derived vesicles ...

How is Toxoplasma able to upregulate host autophagy in the face of robust mTOR activity? Perhaps the parasite, which can export signaling proteins to the host cytosol,10 produces a factor that inhibits the (unknown) mTOR effector that regulates autophagy. However, an intriguing possibility is that the parasite exploits an endogenous host pathway that generates ‘mTOR-resistant’ autophagy, and, as a possible consequence, a natural protein futile cycle. The recent demonstration of elevated protein synthesis, protein degradation, energy expenditure and obesity resistance in mice deficient in branched-chain amino acid (BCAA) catabolism shows the enormous potential thermogenesis associated with such futile cycles.11 While this study did not provide evidence for a regulated mechanism of this kind in wild-type animals, such a mechanism is plausible, as it might provide adaptive benefits.

There is as yet little evidence for mTOR-resistant autophagy in uninfected cells. However, there is evidence for distinct modalities of anabolic mTOR function, since distinct mTOR-dependent phosphorylation sites on the mTOR effector 4E binding protein-1 are controlled through mTOR inputs from either amino acids or insulin.12 It is plausible, then, that an ‘autophagy-sparing’ mode of mTOR activation may exist. It is interesting in this respect that, while mTOR is activated in BCAA catabolism-deficient mice, S6 kinase-1, a canonical effector of mTOR, failed to be activated in certain tissues.11 A similar feature has been noted by us in T. gondii-infected cells (Wang Y, Weiss LM, Orlofsky A, unpublished).

Multiple upstream pathways connect external signals and cellular nutrient and energy status to mTOR activation. If an autophagy-sparing mode of mTOR activation exists, and functions to drive an endogenous thermogenic protein futile cycle, a logical potential upstream stimulus for this event would be amino acid elevation. Amino acids have recently been shown to activate mTOR via a mechanism dependent on calcium and Vps3413, a lipid kinase also implicated in autophagy. Whether autophagic signaling is resistant to amino acid/Vps34-induced mTOR is not yet known. Interestingly, T. gondii induces autophagy in host cells in a manner dependent on both calcium2 and Vps34 (Wang Y, Weiss LM, Orlofsky A, unpublished). It is possible to speculate, then, that amino acid elevation, coupled with an unknown endogenous signal that promotes autophagy in this setting, can generate an autophagy- and mTOR-dependent futile cycle via Vps34, and that Toxoplasma can mimic these upstream signals in order to exploit this mechanism and capture host nutrients. The use of the parasite to examine these and similar hypotheses may provide a fruitful new avenue for the elucidation of protein metabolism and autophagic signaling in mammalian cells.

Acknowledgments

This work was supported by funds from National Institutes of Health grant AI-55358 and by the Flow Cytometry Core of the Center for AIDS Research (AI-51519). The author wishes to thank Dr. Louis Weiss for helpful discussions.

The following abbreviations are used

BCAA
branched-chain amino acids
mTOR
mammalian target of rapamycin
PV
parasitophorous vacuole
ER
endoplasmic reticulum
TORC1
Tor complex 1
LY
lysosome
AA
amino acids
CaM
calcium/calmodulin
ROPS
rhoptry proteins

References

1. Schmid D, Münz C. Innate and adaptive immunity through autophagy. Immunity. 2007;27:11–21. [PubMed]
2. Wang Y, Weiss LM, Orlofsky A. Host cell autophagy is induced by Toxoplasma gondii and contributes to parasite growth. J Biol Chem. 2008 published online Nov 21, 2008. [PMC free article] [PubMed]
3. Martin AM, Liu T, Lynn BC, Sinai AP. The Toxoplasma gondii parasitophorous vacuole membrane: Transactions across the border. J Eukaryot Microbiol. 2007;54:25–8. [PubMed]
4. Fox BA, Gigley JP, Bzik DJ. Toxoplasma gondii lacks the enzymes required for de novo arginine biosynthesis and arginine starvation triggers cyst formation. Int J Parasitol. 2004;34:323–31. [PubMed]
5. Mazumdar J, Striepen B. Make it or take it: fatty acid metabolism of apicomplexan parasites. Eukaryot Cell. 2007;6:1727–35. [PMC free article] [PubMed]
6. Gherardi A, Sarciron ME. Molecules targeting the purine salvage pathway in Apicomplexan parasites. Trends Parasitol. 2007;23:384–9. [PubMed]
7. Mordue DG, Hakansson S, Niesman I, Sibley LD. Toxoplasma gondii resides in a vacuole that avoids fusion with host cell endocytic and exocytic vesicular trafficking pathways. Exp Parasitol. 1999;92:87–99. [PubMed]
8. Coppens I, Dunn JD, Romano JD, Pypaert M, Zhang H, Boothroyd JC, Joiner KA. Toxoplasma gondii sequesters lysosomes from mammalian hosts in the vacuolar space. Cell. 2006;125:261–74. [PubMed]
9. Reeds PJ, Wahle KW, Haggarty P. Energy costs of protein and fatty acid synthesis. Proc Nutr Soc. 1982;41:155–59. [PubMed]
10. Ravindran S, Boothroyd JC. Secretion of proteins into host cells by Apicomplexan parasites. Traffic. 2008;9:647–56. [PubMed]
11. She P, Reid TM, Bronson SK, Vary TC, Hajnal A, Lynch CJ, Hutson SM. Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab. 2007;6:181–94. [PMC free article] [PubMed]
12. Wang XM, Beugnet A, Murakami M, Yamanaka S, Proud CG. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins. Molec Cell Biol. 2005;25:2558–72. [PMC free article] [PubMed]
13. Gulati P, Gaspers LD, Dann SG, Joaquin M, Nobukuni T, Natt F, Kozma SC, Thomas AP, Thomas G. Amino acids activate mTOR Complex 1 via Ca2+/CaM signaling to hVps34. Cell Metab. 2008;7:456–65. [PMC free article] [PubMed]